Navigation Links
Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
Date:12/11/2008

thin 12 weeks of identification of the Centers for Disease Control and Prevention ("CDC") released seasonal strains, or approximately half the time required to manufacture egg-based vaccines. The ability to rapidly respond to the identification of annual seasonal strains may be important in providing timely vaccine in advance of annual physicals for children before the school year.

Seasonal Influenza

The majority of individuals with influenza recover in less than two weeks; however, some may develop life-threatening complications such as pneumonia. In addition, influenza exacerbates the symptoms of chronic health conditions such as diabetes, asthma and congestive heart failure. The most severe disease occurs in infants and young children and adults older than 65 years of age. The CDC reports that 15 to 60 million people in the U.S. contract influenza each year leading to over 200,000 hospitalizations and 36,000 deaths. The Advisory Committee on Immunization Practices ("ACIP"), which has been expanding recommendations for seasonal influenza vaccination for the last several years, currently recommends seasonal influenza vaccination for children 6 months through 18 years of age, pregnant women, adults over 50 years of age, and individuals of any age with chronic health conditions or who are at high risk of influenza disease. Based on the expanding recommendation of vaccination to new age groups, the growing worldwide population to be vaccinated, and the need of an improved influenza vaccine for the elderly, global market projections of seasonal influenza are estimated to increase from $2.8 billion in 2007 to $6.5 billion by 2013.

About Novavax

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx ... today announced a peer-reviewed publication of the results ... evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for the ... controlled adverse environment (CAE ® ) model.  The ... the results, which were previously disseminated by the ...
(Date:5/22/2015)... BOSTON , May 22, 2015   InspireMD, Inc. ... in stent embolic protection systems ("EPS"), today announced that its ... PARADIGM, lead by principle investigator Prof. Piotr Musialek , ... in Paris, France . PARADIGM, ... pe R cutaneous c A roti D revascularization ...
(Date:5/22/2015)... , May 22, 2015 ... phase clinical research unit with a worldwide reputation ... for its frequent publications in peer reviewed medical ... European stakeholders and regulators in discussions about rules ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... offering of senior notes. The Company intends ... a substantial portion of the outstanding borrowings under its credit ... Pierce, Fenner & Smith Incorporated, BNP Paribas Securities Corp. and ...
... 70,737 patients through institutional databases and medical charts, researchers ... determined that only 20 percent of patients with newly ... factors were screened for HBV infection before starting chemotherapy. ... P. Hwang, MD, MPH, the lead author of the ...
Cached Medicine Technology:Zimmer Holdings, Inc. Announces Offering of Senior Notes 2Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection 2
(Date:5/22/2015)... West Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they ... in cosmetic, restorative and other dental treatments. At ... that interest them. Questions regarding what certain treatments ... can also be covered during this initial appointment. ...
(Date:5/22/2015)... 22, 2015 Medivo, Inc., a leader in ... and Genotype Results in ‘Baby Boomers’ Screened for HCV Following ... Lab Test Database” at Digestive Disease Week, May 16-19, 2015. ... and Analytics team members Carol Smyth, MB; Jason Bhan, MD; ... MSI, along with Nancy Reau, MD from the University of ...
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
(Date:5/22/2015)... Jupiter, FL (PRWEB) May 22, 2015 ... Ed Begley, Jr., scheduled to broadcast on Friday, May ... PST, via Discovery Channel. , In this episode Innovations ... companies get back to business quickly through disaster recovery ... NDPTC, a company that works collaboratively to develop and ...
(Date:5/22/2015)... AZ (PRWEB) May 22, 2015 In ... Olympics, Parker and Sons is offering to donate $5 ... installing an AC unit or water softening system. Customers ... behalf; Parker and Sons gets business; and the Special ... , The Special Olympics helps over 4.4 million athletes, ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... Under the scheme 'Assistance for capacity Building', Ministry ... upto a maximum //of Rs. 1.50 crores or ... of emergency facilities of State Hospitals of towns/cities ... with NHAI, Department of Road Transport and Highways ...
... new study by specialists at the Johns Hopkins Children’s ... inner-city children with chronic asthma //gets enough medicine to ... reported in December's Pediatrics, are disturbing, the researchers say, ... 'rescue' drugs after an asthma attack strikes and to ...
... women in Scotland wait for weeks to find out if ... of the Scotland's screening //services in meeting the basic deadlines ... east of Scotland, where one quarter of those tested did ... covering Tayside and Fife admitted the delay as a usual ...
... American Dental association announced on the 9th of November, urging ... of infant formulation. // ,The dentists are concerned about ... be disastrous as instead of protecting teeth it might permanently ... to weakened bones and even bone cancer boys. ,This ...
... scientists to exploit prevailing drugs, already in use ... impeding cognitive //decline in Alzheimer's disease, has borne ... of scientists' attention, offers promise in its perceived ... a foregone conclusion for patients afflicted with Alzheimer's. ...
... Innovation and Improvement suggested that some patients should be cared ... admitting them in the hospital wards. ,The ... Accident and Emergency (A&E) departments that leads to hospital admissions ... numbers admitted in hospital wards. ,Home ...
Cached Medicine News:Health News:City Kids With Asthma Lose Out on Preventive Treatment 2Health News:Scotland Women Wait For Weeks For Getting Breast Cancer Results 2